shouldiuse.io

Categories

VERDICT

Should I use ClinCapture?

We value your privacy - clincapture.com

Depends. A credible fit for small-to-mid biotech, device, and academic teams running regulated trials who want no-code EDC without Medidata-tier pricing. Skip it for non-clinical data capture, enterprise scale, or if you need transparent pricing and a spotless security record.

Confidence

Medium. Based on ~30 public sources; most snippets truncated, so exact pricing figures and funding amounts were unavailable.

Ratings

  • Value for moneyNo public pricing or value data
  • Ease of use
  • Feature depth
  • Support qualityNo support evidence in sources
  • Security posture

Pricing

Not disclosed

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed

Best for

  • Small-to-mid biotech and device trials
  • Teams wanting no-code DIY study build
  • Budget-conscious sponsors avoiding Medidata pricing
  • Academic groups outgrowing REDCap

Not for

  • Big-pharma programs needing enterprise CDMS — Medidata or Veeva territory
  • Anyone not running regulated clinical trials — expensive overkill
  • Buyers who require transparent published pricing or spotless security history

Gotchas - check before you buy

high

CVE-2025-65270 reflected XSS (CVSS 6.1); confirm patch status and version before signing

medium

Guess: pricing is quote-based per study; budget for build, database lock, and support fees beyond license

low

Vendor-commissioned comparisons vs REDCap, Medidata, OpenClinica are marketing; verify independently

Pros and cons

Pros

  • No-code EDC build; positioned against REDCap and Medidata
  • Strong Software Advice rating: 4.9/5 across 21 reviews
  • AI-powered trial build platform launched March 2026
  • Chosen by pharma and medtech startups for ease of use

Cons

  • Thin independent review footprint: one G2 review
  • Ratings diverge sharply: 4.9/5 vs 3.7/5 across sites
  • Comparison pages are vendor-authored marketing

Sources & method

Analyzed 10/05/2026 - 16 sources - One finding: reflected XSS in Captivate EDC (CVE-2025-65270, CVSS 6.1); no breach reports found.

official x3review x5security x3news x5
  • CVE-2025-65270 — Reflected XSS in ClinCapture/Captivate EDC, Reflected cross-site scripting, CVSS 6.1 (medium). Public proof-of-concept on GitHub; patch status unconfirmed in sources.

Key stats

  • Ease of use: 4/5

    Rating

  • Not disclosed

    Starting price

  • 16

    Sources

  • Analyzed

  • Value for money. No public pricing or value data
  • Ease of use: 4/5. No-code build; buyers cited ease of use
  • Feature depth: 4/5. Positioned as most feature-rich open-source EDC
  • Support quality. No support evidence in sources
  • Security posture: 2/5. Public reflected XSS CVE in 2025
  • 4.9/5 Software Advice rating 21 reviews
  • 3.7/5 RFP.wiki rating 42 reviews
  • 1 G2 review count very thin independent footprint
  • Raised Funding amount undisclosed in sources

Pricing

Not disclosed

Security

One finding: reflected XSS in Captivate EDC (CVE-2025-65270, CVSS 6.1); no breach reports found.

  • CVE-2025-65270 — Reflected XSS in ClinCapture/Captivate EDCReflected cross-site scripting, CVSS 6.1 (medium). Public proof-of-concept on GitHub; patch status unconfirmed in sources.⁶

What users say

Ratings lean positive but the verifiable review base is tiny, so user sentiment is hard to judge.

Alternatives

Compare ClinCapture with each alternative.

  • TrialKit

    Mobile-friendly EDC/CTMS alternative compared directly by reviewers

Companies that use it

  • Hallux12
  • Providence Medical Technology13
  • MediciNova14
Full analysis

Based on ~30 public sources; most snippets truncated, so exact pricing figures and funding amounts were unavailable.

Validated no-code EDC for small/mid trials; thin reviews, hidden pricing, one 2025 XSS CVE. Not for non-clinical use.

Methodology

Based on ~30 public sources; most snippets truncated, so exact pricing figures and funding amounts were unavailable.

Sources

  1. review
  2. review
  3. review
  4. review
  5. review
  6. security
  7. security
  8. security
  9. official
  10. official
  11. official
  12. news
  13. news
  14. news
  15. news
  16. news

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.